REVELATION OF PSEUDO-MASK OF SPIRITUAL FIGURES IN RUTH PRAWER JHABVALA'S HEAT AND DUST by Naveen K. MEHTA

Get full text

SUFFERING: BLESSING IN DISGUISE (EXPLORING KĀLIDĀSA’S ABHIJÑĀNAŚĀKUNTALAM AND SHAKESPEARE’S OTHELLO) by Dr. Naveen K Mehta

Get full text

EXPLORING FATHER-DAUGHTER RELATIONSHIP IN THE ABHIJNANSAKUNTALAM AND HAMLET by Dr. Naveen K. MEHTA

Get full text

Revisiting Indian myths in Githa Hariharan’s The thousand faces of night. A critical perspective by Soumya TIWARI, Naveen K. MEHTA

Get full text

A Study of Customer Relationship Management Practices in Madhya Pradesh State Tourism Services by Dharmendra MEHTA, Jitendra K. SHARMA, Naveen K. MEHTA

Get full text

A Study of Customer Relationship Management Practices in Madhya Pradesh State Tourism Services by Dharmendra MEHTA, Jitendra K. SHARMA, Naveen K. MEHTA

Get full text

An Exploratory Study on Implementation of Lean Manufacturing Practices(With Special Reference to Automobile Sector Industry)(Yalın İmalat Faaliyetine Yönelik Bir Uygulama (Otomobil... by Er. Rajesh Kumar MEHTA, Dhermendra MEHTA, Naveen K. MEHTA

Get full text

Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors by Kerry A. Whalen, Kavya Rakhra, Naveen K. Mehta, Alexander Steinle, Jennifer S. Michaelson, Patrick A. Baeuerle

Get full text

Order of administration of combination cytokine therapies can decouple toxicity from efficacy in syngeneic mouse tumor models by Adrienne Rothschilds, Alice Tzeng, Naveen K. Mehta, Kelly D. Moynihan, Darrell J. Irvine, K. Dane Wittrup

Get full text

Intratumoral injection and retention hold promise to improve cytokine therapies for cancer by Karsten Sauer, Kavya Rakhra, Kaida Wu, Naveen K. Mehta, Jennifer S. Michaelson, Patrick A. Baeuerle, Patrick A. Baeuerle

Get full text

1024 CLN-978, a novel CD19/CD3/HSA T cell engager with extended serum half-life, is effective against lymphoma cells expressing very low levels of CD19 by Agapitos Patakas, Naveen K Mehta, Patrick A Baeuerle, Jennifer S Michaelson, Kristan A Meetze, Hannah M Findlay, Timothy B London

CLN-978, a novel half-life extended CD19/CD3/HSA-specific T cell-engaging antibody construct with potent activity against B-cell malignancies with low CD19 expression by Agapitos Patakas, Bochong Li, Naveen K Mehta, Kristan Meetze, Patrick A Baeuerle, Jennifer S Michaelson, Hannah M Findlay, Timothy B London

Get full text

1093 CLN-617 combines IL-2 and IL-12 in a single molecule to optimally balance safety and efficacy upon intratumoral injection by Naveen K Mehta, Patrick A Baeuerle, Jennifer S Michaelson, Laura Liu, K Dane Wittrup, Kristan A Meetze, Irina M Shapiro, Kavya Rakhra

1171 CLN-418, a clinical-stage B7H4 x 4–1BB bispecific antibody with potential to treat patients with a wide range of solid tumors by Yun He, Ella Ioffe, Bing Huang, Naveen K Mehta, Patrick A Baeuerle, Jennifer S Michaelson, Kristan A Meetze, Irina M Shapiro, Hanna Dobrowolska

771 A phase 1 study to assess safety, efficacy, pharmacokinetics, and pharmacodynamics of intratumoral CLN-617 (IL2/IL12 fusion protein) combined with pembrolizumab in patients wit... by Evan Hall, Adi Diab, Sajeve Thomas, Randy Sweis, Anthony El-Khoueiry, Naveen K Mehta, Jennifer S Michaelson, Laura Liu, Reham Abdel-Wahab, Jeffrey A Jones, Kaida Wu, Benjamin S Maciejewski

A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL by Melanie Märklin, Gundram Jung, Jonas S Heitmann, Joseph Kauer, Helmut R Salih, Stefanie Mueller, Bochong Li, Latifa Zekri, Naveen K Mehta, Martin Pfluegler, Kristan Meetze, Isabelle Sindel, Fabian Vogt, Lukas Osburg, Hans-Jörg Bühring, Sebastian Hörner, Patrick A Baeuerle, Jennifer S Michaelson

Get full text